Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Terlizzi

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Clinical and Translational Radiation Oncology|March 31, 2025
Stereotactic body radiotherapy for lung oligometastatic prostate cancer: An international retrospective multicenter studyMaximilien Rogé, Patrick Bowden, Paul Conway, et al.
Frontiers in Immunology|November 10, 2022
Immune-related arthritis following pelvic radiation therapy in a patient with lung cancer receiving long-term immune checkpoint blocker treatment: Case reportMihaela Aldea, Rakiba Belkhir, Emeline Colomba, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|July 26, 2023
Primary Bladder Sarcoma: A multi-institutional experience from the Rare Cancer NetworkPiero Bettoli, ZhihuiAmy Liu, Natalia Jara, et al.
Cancer Treatment Reviews|September 21, 2023
Managing postoperative biochemical relapse in prostate cancer, from the perspective of the Francophone group of Urological radiotherapy (GFRU)Loic Ah-Thiane, Paul Sargos, Olivier Chapet, et al.
Practical Radiation Oncology|July 10, 2024
Urinary Organs at Risk for Prostate Cancer External Beam Radiation Therapy: Contouring Guidelines on Behalf of the Francophone Group of Urological Radiation TherapyJennifer Le Guévelou, Thomas Zilli, Ludovic Ferretti, et al.
Acta Oncologica (Stockholm, Sweden)|July 1, 2021
Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to upfront surgeryMario Terlizzi, Etienne Buscail, Olayidé Boussari, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 13, 2023
Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy groupKanta Ka, Renaud Schiappa, Mario Terlizzi, et al.
Drugs|May 5, 2022
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate CancerRonan Flippot, Anna Patrikidou, Mihaela Aldea, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 15, 2025
High-Dose-Rate brachytherapy for salvage treatment of prostate cancer recurrence post-prostatectomy and radiotherapy: A multicenter retrospective analysis (HDR-REPOPRA) by UroGECAdam Kluska, Artur J Chyrek, Benjamin Guix, et al.
International Journal of Radiation Oncology, Biology, Physics|March 21, 2026
Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS multicentric retrospective studyEwen Anger, Stephane Supiot, Quentin Josset, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical and Translational Radiation Oncology|March 31, 2025
Stereotactic body radiotherapy for lung oligometastatic prostate cancer: An international retrospective multicenter studyMaximilien Rogé, Patrick Bowden, Paul Conway, et al.
Frontiers in Immunology|November 10, 2022
Immune-related arthritis following pelvic radiation therapy in a patient with lung cancer receiving long-term immune checkpoint blocker treatment: Case reportMihaela Aldea, Rakiba Belkhir, Emeline Colomba, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|July 26, 2023
Primary Bladder Sarcoma: A multi-institutional experience from the Rare Cancer NetworkPiero Bettoli, ZhihuiAmy Liu, Natalia Jara, et al.
Cancer Treatment Reviews|September 21, 2023
Managing postoperative biochemical relapse in prostate cancer, from the perspective of the Francophone group of Urological radiotherapy (GFRU)Loic Ah-Thiane, Paul Sargos, Olivier Chapet, et al.
Practical Radiation Oncology|July 10, 2024
Urinary Organs at Risk for Prostate Cancer External Beam Radiation Therapy: Contouring Guidelines on Behalf of the Francophone Group of Urological Radiation TherapyJennifer Le Guévelou, Thomas Zilli, Ludovic Ferretti, et al.
Acta Oncologica (Stockholm, Sweden)|July 1, 2021
Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to upfront surgeryMario Terlizzi, Etienne Buscail, Olayidé Boussari, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 13, 2023
Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy groupKanta Ka, Renaud Schiappa, Mario Terlizzi, et al.
Drugs|May 5, 2022
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate CancerRonan Flippot, Anna Patrikidou, Mihaela Aldea, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 15, 2025
High-Dose-Rate brachytherapy for salvage treatment of prostate cancer recurrence post-prostatectomy and radiotherapy: A multicenter retrospective analysis (HDR-REPOPRA) by UroGECAdam Kluska, Artur J Chyrek, Benjamin Guix, et al.
International Journal of Radiation Oncology, Biology, Physics|March 21, 2026
Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS multicentric retrospective studyEwen Anger, Stephane Supiot, Quentin Josset, et al.
Pageof 4